Join
Live feed
·
PRReleasevia Quantisnow
Enlivex Ltd. logo

Enlivex Announces Cost Reduction Plan to Focus Resources on Phase 2b Trial of Allocetra™ in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis

ByQuantisnow·Wall Street's wire, on your screen.
ENLV· Enlivex Ltd.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ENLV (Enlivex Ltd.) and more on Quantisnow.